#France #PROTEOR #ICARUS #KyronMAX #Dijon

PROTEOR Revolutionizes Prosthetics with 3D Printing

In a remarkable leap forward for the field of prosthetics and orthotics (O&P), PROTEOR, a renowned leader in the industry, has announced the launch of a pioneering digital solution. This includes the introduction of the first-ever non-vase mode definitive socket, fabricated through advanced 3D printing technology. This innovative approach promises to redefine the production of prosthetic devices by improving efficiency and customization.

Pioneering Technology with KyronMAX®

The groundbreaking non-vase mode definitive socket is made from KyronMAX®, a proprietary material created through a unique partnership with the Mitsubishi Chemical Group. This advanced material boasts impressive tensile strength and toughness, making it suitable for producing prosthetic sockets that comply with ISO 10328 standards when using the PROTEOR ICARUS 3D Printer. This marks a significant shift from conventional fabrication methods, as the 3D printing approach not only increases quality but also delivers a better tailored fit for each user.

Mike Gorski, General Manager of Proteor Printing Solutions, emphasized the company's commitment to harnessing the most cutting-edge 3D printing technologies. He stated, "We are delivering what the industry has been waiting for—high-quality, in-house 3D printed definitive sockets with a streamlined workflow process." This innovation comes after the acquisition of Filament Innovations, which has greatly influenced their approach toward simplifying the production process of definitive sockets.

Efficient Production and Enhanced Care

The strategic integration of ORTEN software along with the ICARUS 3D Printer allows clinical practitioners to produce prosthetic sockets in-house within a few hours. This efficiency is a game changer in the O&P field, where timely delivery and customization are critical for patient care. The technology has undergone thorough scientific validation to ensure its reliability and efficacy, ensuring that patients receive the best care possible without unnecessary delays.

By transitioning to a non-vase mode design, PROTEOR not only leads technological advancement but also sets new standards in how prosthetics are manufactured and provided. Through this technological revolution, the company aims to ensure that patients receive not just a product, but a solution tailored to their unique needs.

PROTEOR Digital Suite Launch

To further support its digital ambitions, PROTEOR is set to unveil the comprehensive PROTEOR Digital Suite in May. Featuring an array of solutions in scanning, software, and printing services, this unified platform is crafted to optimize workflows and enhance clinical outcomes. The integration of these digital solutions is aimed at maximizing efficiency while improving patient experiences.

By pushing the boundaries of what is possible in O&P, PROTEOR’s latest advancements underline its ongoing commitment to innovate. This transformative approach not only enhances the mode of prosthetics production but also aligns with the dynamic needs of modern healthcare, paving the way for a future where advanced technology seamlessly melds into everyday clinical practices.

For more information, media inquiries can be directed to:

• - Eric Ferris

Vice President, Global Marketing & Product Management
PROTEOR
Email: [email protected]
Phone: +1.855.450.7500

• - Alexandra Houiste

Manager, Corporate Communications
PROTEOR
Email: [email protected]
Phone: +33 3 80 78 42 42

Conclusion

PROTEOR is undoubtedly shaping the future of prosthetics through innovation and strategic partnerships. With the ability to produce quality prosthetic solutions more rapidly and reliably, they are setting the benchmark for the orthotics and prosthetics industry. The era of advanced, patient-centric prosthetic solutions has arrived, thanks to PROTEOR's groundbreaking work in 3D printing technology.